A 2023 study from a team at the University of Wisconsin-Madison demonstrated the promise of fragmentomics. Researchers used machine learning to identify patterns in fragments of circulating tumor DNA, which is genetic material that cancerous tumors shed into the bloodstream as they grow. The researchers trained an algorithm to not only detect cancer in blood samples but also to identify the specific type of cancer present.
Office of Strategic Communication